NeoGenomics, Inc. ( NEO) - Key Metrics
NEO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.78 | $0.09 | $0.77 | $0.45 |
| 2026Q1 | $7.23 | -$0.66 | -$0.31 | -$0.51 |
| 2025Q4 | $7.39 | -$0.38 | $0.05 | -$0.25 |
| 2025Q3 | $7.34 | -$1.06 | $0.35 | $0.02 |
| 2025Q2 | $7.09 | -$1.76 | $0.79 | $0.55 |
NEO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 36.48 |
| 2026Q1 | 0% | -2.85 |
| 2025Q4 | 0% | -7.66 |
| 2025Q3 | 0% | -1.84 |
| 2025Q2 | 0% | -1.04 |
NEO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.10% | 0% |
| 2026Q1 | -6.85% | 0% |
| 2025Q4 | -2.16% | 0% |
| 2025Q3 | 0.29% | 0% |
| 2025Q2 | 7.49% | 0% |
NEO
Price: $17.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 437800
Ebitda: 2.2 millionMarket Capitalization: 446.6 million